Hemorrhagic shock activation of NLRP3 inflammasome in lung endothelial cells

Journal of Immunology

Volumn 187, Issue 9, 2011, Pages 4809-4817

  Xiang, Meng ^a,b   Shi, Xiaolian ^a,c   Li, Yuehua ^a,d   Xu, Jia ^a,e   Yin, Lianhua ^b   Xiao, Guozhi ^a   Scott, Melanie J ^a   Billiar, Timothy R ^a   Wilson, Mark A ^a,d   Fan, Jie ^a,d  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b FUDAN UNIVERSITY   (China)

^c MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; CRYOPYRIN; HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; THIOREDOXIN INTERACTING PROTEIN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4;

ACUTE LUNG INJURY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENDOTHELIUM CELL; ENZYME ACTIVATION; HEMORRHAGIC SHOCK; INFLAMMATION; LUNG ENDOTHELIUM; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

ANIMALS; CARRIER PROTEINS; CELLS, CULTURED; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; HMGB1 PROTEIN; INFLAMMASOMES; INTERLEUKIN-1BETA; LUNG; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; RESPIRATORY MUCOSA; SHOCK, HEMORRHAGIC;

EID: 80555126061     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1102093     Document Type: Article

References (61)

1. Zanetti, G., J. D. Baumgartner, and M. P. Glauser. 1997. Sepsis and septic shock. Schweiz. Med. Wochenschr. 127: 489-499. (Pubitemid 27165456)
2. Glauser, M. P., G. Zanetti, J. D. Baumgartner, and J. Cohen. 1991. Septic shock: pathogenesis. Lancet 338: 732-736.
3. Fowler, A. A., R. F. Hamman, J. T. Good, K. N. Benson, M. Baird, D. J. Eberle, T. L. Petty, and T. M. Hyers. 1983. Adult respiratory distress syndrome: risk with common predispositions. Ann. Intern. Med. 98: 593-597. (Pubitemid 13091168)
4. Liu, Y., Y. Yuan, Y. Li, J. Zhang, G. Xiao, Y. Vodovotz, T. R. Billiar, M. A. Wilson, and J. Fan. 2009. Interacting neuroendocrine and innate and acquired immune pathways regulate neutrophil mobilization from bone marrow following hemorrhagic shock. J. Immunol. 182: 572-580.
5. Fan, J., Y. Li, Y. Vodovotz, T. R. Billiar, and M. A. Wilson. 2006. Hemorrhagic shock-activated neutrophils augment TLR4 signaling-induced TLR2 upregulation in alveolar macrophages: role in hemorrhage-primed lung inflammation. Am. J. Physiol. Lung Cell. Mol. Physiol. 290: L738-L746. (Pubitemid 43725079)
6. Fan, J., J. C. Marshall, M. Jimenez, P. N. Shek, J. Zagorski, and O. D. Rotstein. 1998. Hemorrhagic shock primes for increased expression of cytokine-induced neutrophil chemoattractant in the lung: role in pulmonary inflammation following lipopolysaccharide. J. Immunol. 161: 440-447. (Pubitemid 28285553)
7. Orfanos, S. E., I. Mavrommati, I. Korovesi, and C. Roussos. 2004. Pulmonary endothelium in acute lung injury: from basic science to the critically ill. Intensive Care Med. 30: 1702-1714. (Pubitemid 39297172)
8. Matthay, M. A., G. A. Zimmerman, C. Esmon, J. Bhattacharya, B. Coller, C. M. Doerschuk, J. Floros, M. A. Gimbrone, Jr., E. Hoffman, R. D. Hubmayr, et al. 2003. Future research directions in acute lung injury: summary of a National Heart, Lung, and Blood Institute working group. Am. J. Respir. Crit. Care Med. 167: 1027-1035. (Pubitemid 36408170)
9. Roumen, R. M., T. Hendriks, J. van der Ven-Jongekrijg, G. A. Nieuwenhuijzen, R. W. Sauerwein, J. W. van der Meer, and R. J. Goris. 1993. Cytokine patterns in patients after major vascular surgery, hemorrhagic shock, and severe blunt trauma. Relation with subsequent adult respiratory distress syndrome and multiple organ failure. Ann. Surg. 218: 769-776. (Pubitemid 24005822)
10. Roumen, R. M., H. Redl, G. Schlag, G. Zilow, W. Sandtner, W. Koller, T. Hendriks, and R. J. Goris. 1995. Inflammatory mediators in relation to the development of multiple organ failure in patients after severe blunt trauma. Crit. Care Med. 23: 474-480.
11. Zhu, X. L., R. Zellweger, X. H. Zhu, A. Ayala, and I. H. Chaudry. 1995. Cytokine gene expression in splenic macrophages and Kupffer cells following haemorrhage. Cytokine 7: 8-14.
12. Shenkar, R., and E. Abraham. 1993. Effects of hemorrhage on cytokine gene transcription. Lymphokine Cytokine Res. 12: 237-247. (Pubitemid 23264836)
13. Shenkar, R., W. F. Coulson, and E. Abraham. 1994. Hemorrhage and resuscitation induce alterations in cytokine expression and the development of acute lung injury. Am. J. Respir. Cell Mol. Biol. 10: 290-297.
14. Abraham, E., N. J. Richmond, and Y. H. Chang. 1988. Effects of hemorrhage on interleukin-1 production. Circ. Shock 25: 33-40.
15. Rao, D. A., K. J. Tracey, and J. S. Pober. 2007. IL-1alpha and IL-1beta are endogenous mediators linking cell injury to the adaptive alloimmune response. J. Immunol. 179: 6536-6546.
16. Tschopp, J., and K. Schroder. 2010. NLRP3 inflammasome activation: The convergence of multiple signalling pathways on ROS production? Nat. Rev. Immunol. 10: 210-215.
17. Schroder, K., and J. Tschopp. 2010. The inflammasomes. Cell 140: 821-832.
18. Martinon, F., K. Burns, and J. Tschopp. 2002. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol. Cell 10: 417-426. (Pubitemid 35007355)
19. Zhou, R., A. Tardivel, B. Thorens, I. Choi, and J. Tschopp. 2010. Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat. Immunol. 11: 136-140.
20. Babior, B. M. 2000. The NADPH oxidase of endothelial cells. IUBMB Life 50: 267-269. (Pubitemid 32289084)
21. Griendling, K. K., D. Sorescu, and M. Ushio-Fukai. 2000. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ. Res. 86: 494-501. (Pubitemid 30165039)
22. Xiang, M., L. Yin, Y. Li, G. Xiao, Y. Vodovotz, T. R. Billiar, M. A. Wilson, and J. Fan. 2011. Hemorrhagic shock activates lung endothelial reduced nicotinamide adenine dinucleotide phosphate (NADPH) oxidase via neutrophil NADPH oxidase. Am. J. Respir. Cell Mol. Biol. 44: 333-340.
23. Wang, H., O. Bloom, M. Zhang, J. M. Vishnubhakat, M. Ombrellino, J. Che, A. Frazier, H. Yang, S. Ivanova, L. Borovikova, et al. 1999. HMG-1 as a late mediator of endotoxin lethality in mice. Science 285: 248-251. (Pubitemid 29329996)
24. Yang, H., M. Ochani, J. Li, X. Qiang, M. Tanovic, H. E. Harris, S. M. Susarla, L. Ulloa, H. Wang, R. DiRaimo, et al. 2004. Reversing established sepsis with antagonists of endogenous high-mobility group box 1. Proc. Natl. Acad. Sci. USA 101: 296-301. (Pubitemid 38084244)
25. Matzinger, P. 2002. The danger model: a renewed sense of self. Science 296: 301-305. (Pubitemid 34303674)
26. Seong, S. Y., and P. Matzinger. 2004. Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses. Nat. Rev. Immunol. 4: 469-478. (Pubitemid 38745558)
27. Zeh, H. J., III, and M. T. Lotze. 2005. Addicted to death: invasive cancer and the immune response to unscheduled cell death. J. Immunother. 28: 1-9.
28. Kim, J. Y., J. S. Park, D. Strassheim, I. Douglas, F. Diaz Del Valle, K. Asehnoune, S. Mitra, S. H. Kwak, S. Yamada, I. Maruyama, et al. 2005. HMGB1 contributes to the development of acute lung injury after hemorrhage. Am. J. Physiol. Lung Cell Mol. Physiol. 288: L958-L965. (Pubitemid 40547924)
29. Yang, R., T. Harada, K. P. Mollen, J. M. Prince, R. M. Levy, J. A. Englert, M. Gallowitsch-Puerta, L. Yang, H. Yang, K. J. Tracey, et al. 2006. Anti- HMGB1 neutralizing antibody ameliorates gut barrier dysfunction and improves survival after hemorrhagic shock. Mol. Med. 12: 105-114. (Pubitemid 44454098)
30. Peltz, E. D., E. E. Moore, P. C. Eckels, S. S. Damle, Y. Tsuruta, J. L. Johnson, A. Sauaia, C. C. Silliman, A. Banerjee, and E. Abraham. 2008. HMGB1 is markedly elevated within six hours of mechanical trauma in humans. Shock 32: 17-22.
31. Fan, J., Y. Li, R. M. Levy, J. J. Fan, D. J. Hackam, Y. Vodovotz, H. Yang, K. J. Tracey, T. R. Billiar, and M. A. Wilson. 2007. Hemorrhagic shock induces NAD(P)H oxidase activation in neutrophils: role of HMGB1-TLR4 signaling. J. Immunol. 178: 6573-6580. (Pubitemid 46717441)
32. Li, Y., M. Xiang, Y. Yuan, G. Xiao, J. Zhang, Y. Jiang, Y. Vodovotz, T. R. Billiar, M. A. Wilson, and J. Fan. 2009. Hemorrhagic shock augments lung endothelial cell activation: role of temporal alterations of TLR4 and TLR2. Am. J. Physiol. Regul. Integr. Comp. Physiol. 297: R1670-R1680.
33. Tsung, A., R. A. Hoffman, K. Izuishi, N. D. Critchlow, A. Nakao, M. H. Chan, M. T. Lotze, D. A. Geller, and T. R. Billiar. 2005. Hepatic ischemia/reperfusion injury involves functional TLR4 signaling in nonparenchymal cells. J. Immunol. 175: 7661-7668. (Pubitemid 41713466)
34. Kaczorowski, D. J., K. P. Mollen, R. Edmonds, and T. R. Billiar. 2008. Early events in the recognition of danger signals after tissue injury. J. Leukoc. Biol. 83: 546-552. (Pubitemid 351966863)
35. Assier, E., V. Jullien, J. Lefort, J. L. Moreau, J. P. Di Santo, B. B. Vargaftig, J. R. Lapa e Silva, and J. Thèze. 2004. NK cells and polymorphonuclear neutrophils are both critical for IL-2-induced pulmonary vascular leak syndrome. J. Immunol. 172: 7661-7668. (Pubitemid 38747632)
36. Fan, J., R. S. Frey, and A. B. Malik. 2003. TLR4 signaling induces TLR2 expression in endothelial cells via neutrophil NADPH oxidase. J. Clin. Invest. 112: 1234-1243. (Pubitemid 38056300)
37. Cotter, M. J., K. E. Norman, P. G. Hellewell, and V. C. Ridger. 2001. A novel method for isolation of neutrophils from murine blood using negative immunomagnetic separation. Am. J. Pathol. 159: 473-481. (Pubitemid 32751078)
38. -/-) mice interferes with increase in lung microvascular permeability. Circ. Res. 91: 70-76.
39. Lamkanfi, M. 2011. Emerging inflammasome effector mechanisms. Nat. Rev. Immunol. 11: 213-220.
40. Fisher, C. J., Jr., S. M. Opal, S. F. Lowry, J. C. Sadoff, J. F. LaBrecque, H. C. Donovan, J. L. Lookabaugh, J. Lemke, J. P. Pribble, S. C. Stromatt, et al. 1994. Role of interleukin-1 and the therapeutic potential of interleukin-1 receptor antagonist in sepsis. Circ. Shock 44: 1-8.
41. Fisher, C. J., Jr., J. F. Dhainaut, S. M. Opal, J. P. Pribble, R. A. Balk, G. J. Slotman, T. J. Iberti, E. C. Rackow, M. J. Shapiro, R. L. Greenman, et al. 1994. Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group. JAMA 271: 1836-1843.
42. Opal, S. M., C. J. Fisher, Jr., J. F. Dhainaut, J. L. Vincent, R. Brase, S. F. Lowry, J. C. Sadoff, G. J. Slotman, H. Levy, R. A. Balk, et al. 1997. Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group. Crit. Care Med. 25: 1115-1124. (Pubitemid 27310249)
43. Abraham, E. 1999. Why immunomodulatory therapies have not worked in sepsis. Intensive Care Med. 25: 556-566. (Pubitemid 29312588)
44. Huber, T. S., G. C. Gaines, M. B. Welborn, III, J. J. Rosenberg, J. M. Seeger, and L. L. Moldawer. 2000. Anticytokine therapies for acute inflammation and the systemic inflammatory response syndrome: IL-10 and ischemia/reperfusion injury as a new paradigm. Shock 13: 425-434.
45. Abraham, E., J. Arcaroli, A. Carmody, H. Wang, and K. J. Tracey. 2000. HMG-1 as a mediator of acute lung inflammation. J. Immunol. 165: 2950-2954.
46. Erlandsson Harris, H., and U. Andersson. 2004. Mini-review: The nuclear protein HMGB1 as a proinflammatory mediator. Eur. J. Immunol. 34: 1503-1512. (Pubitemid 39256031)
47. Andersson, U., H. Wang, K. Palmblad, A. C. Aveberger, O. Bloom, H. Erlandsson-Harris, A. Janson, R. Kokkola, M. Zhang, H. Yang, and K. J. Tracey. 2000. High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J. Exp. Med. 192: 565-570. (Pubitemid 30666257)
48. Czura, C. J., and K. J. Tracey. 2003. Targeting high mobility group box 1 as a late-acting mediator of inflammation. Crit. Care Med. 31(1 Suppl): S46-S50. (Pubitemid 36143477)
49. Wang, H., H. Yang, C. J. Czura, A. E. Sama, and K. J. Tracey. 2001. HMGB1 as a late mediator of lethal systemic inflammation. Am. J. Respir. Crit. Care Med. 164: 1768-1773. (Pubitemid 33152308)
50. Orlova, V. V., E. Y. Choi, C. Xie, E. Chavakis, A. Bierhaus, E. Ihanus, C. M. Ballantyne, C. G. Gahmberg, M. E. Bianchi, P. P. Nawroth, and T. Chavakis. 2007. A novel pathway of HMGB1-mediated inflammatory cell recruitment that requires Mac-1-integrin. EMBO J. 26: 1129-1139.
51. Hori, O., J. Brett, T. Slattery, R. Cao, J. Zhang, J. X. Chen, M. Nagashima, E. R. Lundh, S. Vijay, D. Nitecki, et al. 1995. The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system. J. Biol. Chem. 270: 25752-25761.
52. Huttunen, H. J., C. Fages, and H. Rauvala. 1999. Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kappaB require the cytoplasmic domain of the receptor but different downstream signaling pathways. J. Biol. Chem. 274: 19919-19924.
53. Huttunen, H. J., C. Fages, J. Kuja-Panula, A. J. Ridley, and H. Rauvala. 2002. Receptor for advanced glycation end products-binding COOH-terminal motif of amphoterin inhibits invasive migration and metastasis. Cancer Res. 62: 4805-4811.
54. Park, J. S., D. Svetkauskaite, Q. He, J. Y. Kim, D. Strassheim, A. Ishizaka, and E. Abraham. 2004. Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J. Biol. Chem. 279: 7370-7377. (Pubitemid 38294612)
55. Park, J. S., F. Gamboni-Robertson, Q. He, D. Svetkauskaite, J. Y. Kim, D. Strassheim, J. W. Sohn, S. Yamada, I. Maruyama, A. Banerjee, et al. 2006. High mobility group box 1 protein interacts with multiple Toll-like receptors. Am. J. Physiol. Cell Physiol. 290: C917-C924.
56. Tsung, A., R. Sahai, H. Tanaka, A. Nakao, M. P. Fink, M. T. Lotze, H. Yang, J. Li, K. J. Tracey, D. A. Geller, and T. R. Billiar. 2005. The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion. J. Exp. Med. 201: 1135-1143. (Pubitemid 40524681)
57. Fan, J., Y. Li, Y. Vodovotz, T. R. Billiar, and M. A. Wilson. 2007. Neutrophil NAD(P)H oxidase is required for hemorrhagic shock-enhanced TLR2 up-regulation in alveolar macrophages in response to LPS. Shock 28: 213-218. (Pubitemid 47220834)
58. Impellizzeri, D., E. Esposito, E. Mazzon, I. Paterniti, R. Di Paola, P. Bramanti, and S. Cuzzocrea. 2011. Effect of apocynin, a NADPH oxidase inhibitor, on acute lung inflammation. Biochem. Pharmacol. 81: 636-648.
59. Al-Mehdi, A. B., G. Zhao, C. Dodia, K. Tozawa, K. Costa, V. Muzykantov, C. Ross, F. Blecha, M. Dinauer, and A. B. Fisher. 1998. Endothelial NADPH oxidase as the source of oxidants in lungs exposed to ischemia or high K+. Circ. Res. 83: 730-737. (Pubitemid 28462787)
60. Dostert, C., V. Pétrilli, R. Van Bruggen, C. Steele, B. T. Mossman, and J. Tschopp. 2008. Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 320: 674-677. (Pubitemid 351928351)
61. Pétrilli, V., S. Papin, C. Dostert, A. Mayor, F. Martinon, and J. Tschopp. 2007. Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration. Cell Death Differ. 14: 1583-1589. (Pubitemid 47278844)